
Early MASH risk stratification, drug choice, and aligned coverage could improve outcomes, explained Zobair Younossi, MD.
The American Journal of Managed Care
almost 26 years ago
Indirect Cost of Ischemic Heart Disease to Employersalmost 26 years ago
Disenrollment from Medicare HMOsalmost 26 years ago
A Comparison of Abciximab Use in MCO and Non-MCO Populationsalmost 26 years ago
The Employer's Perspectivealmost 26 years ago
Is the Healthcare Workforce a Barrier to Cost Containment?almost 26 years ago
Is the Healthcare Workforce a Barrier to Cost Containment?almost 26 years ago
Is the Healthcare Workforce a Barrier to Cost Containment?almost 26 years ago
Is the Healthcare Workforce a Barrier to Cost Containment?





